OXFORD, UK, August 27th, 2014
PharmaVentures is pleased to announce that it acted as exclusive advisor on the sale of Medical Insight, the Danish enterprise imaging software company, to Karos Health, based in Ontario, Canada. The sale was completed in June and announced yesterday by Karos Health.
PharmaVentures CEO, Dr Fintan Walton said, “We are delighted to have been advisors to Medical Insight in this important sector. This success follows a string of recent global M&A deals advised by us including the recent sale of a biologics manufacturing facility in the US on behalf of a major US pharmaceutical company.”
Ping Shek, PharmaVentures’ lead advisor on the transaction added ‘Inter-operability and cross-enterprise workflow solutions, as well as mobility, are increasingly important components in the delivery of healthcare services such as diagnostic imaging services. Software and ICT groups in healthcare are increasingly looking to acquire businesses in these areas where they can play strategically into their customer network’.
- ends -